(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

CONJUGADO DE ANTICORPO ANTI-B7H3-ANÁLOGO DE EXATECANO E USO MEDICINAL DO MESMO

Em ExigênciaInvention PatentPCT · CN2019107852

Application data

Number

112021004829

Type

Invention Patent

Filing

09/25/2019

Publication

06/08/2021

PCT

CN2019107852

Progress at the INPI

Technical opinion to answer
  1. Filing09/25/19
  2. Publication06/08/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/31/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CHANGZHOU HANSOH PHARMACEUTICAL CO., LTD.

CN

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.

CN

JIANGSU HENGRUI MEDICINE CO., LTD.

CN

SHANGHAI HANSOH BIOMEDICAL CO., LTD.

CN

SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD

CN

Inventors

H. Y. (pessoa física)

CN

J. X. (pessoa física)

CN

L. Z. (pessoa física)

CN

L. Z. (pessoa física)

CN

T. Z. (pessoa física)

CN

W. T. (pessoa física)

CN

Technical data

Priority claims

CN

201811156667.5 · 09/30/2018

Abstract

São descritos pela presente invenção um conjugado de análogo de anticorpo anti-B7H3-exatecano, um método de preparação do mesmo e um uso medicinal antitumor do mesmo.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

03/31/2026

RPI 2882

Transferência deferida

#25.1

06/13/2023

RPI 2736

Notificação de entrada na fase nacional - PCT

#1.3

06/08/2021

RPI 2631

Alteração de dados cadastrais

#1.1

03/23/2021

RPI 2620

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.